TIMOTHY MANSOURI: Open Payments
NPI 1770970899 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 60 payments from 11 companies in 2025. Trend: 2023 $506 · 2024 $1,139 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 13 | $267 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $266 |
| ABBVIE INC. | 20 | $235 |
| Vertex Pharmaceuticals Incorporated | 3 | $75 |
| Merz Pharmaceuticals, LLC | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Bioventus LLC | 1 | $34 |
| Forte Bio-Pharma LLC | 2 | $34 |
| SCILEX PHARMACEUTICALS INC. | 2 | $31 |
| Electronic Waveform Lab, Inc. | 1 | $25 |
Products named: IBSRELA, RELISTOR, QULIPTA, UBRELVY, JOURNAVX, Xeomin, Symbravo, EXOGEN ULTRASOUND BONE HEALING SYSTEM.
Industry payments across CA — which companies pay providers there.
